Most Recent
The identity of a Big Six partner to whom a former AMP lawyer allegedly criticised her superior has been revealed in court during a heated exchange between the barristers in the unfair dismissal proceeding.
Investigations by ASIC led to prosecutors laying 279 criminal charges in the last six months of 2019, an increase of 300 percent on the previous six months, the corporate watchdog's latest report reveals.
A property developer facing a class action over a residential complex in Canberra has asked a court to reopen a hearing that resulted in a finding that it misled the lead applicant about the GST payable on her unit and awarded her $23,400 in compensation.
The Fair Work Commission has lavished praise on a Herbert Smith Freehills lawyer for his persuasive advocacy skills in representing transport company Greyhound in unfair dismissal proceedings.
The Queensland government is seeking court orders that put dam operators Seqwater and Sunwater on the hook for the vast majority of damages after a class action judgment found negligence in the lead up to the state's 2011 floods that destroyed 2,000 homes.
The COVID-19 pandemic and government social distancing restrictions were reasons to be flexible in applying and adapting the law, the judge overseeing the administration of Virgin Australia has said in exempting administrators from liability for unpaid leases and allowing Thursday's meeting of the airlines' creditors to be held by teleconference.
A date has been set in Domino’s bid to strike out parts of the statement of claim in a class action alleging franchisees underpaid thousands of workers across Australia for five years.
A former privacy regulator will investigate a data breach by the Federal Court that exposed the real names of hundreds of asylum seekers on its website.
A law firm with a global footprint is facing a possible breach of trust lawsuit in relation to $27 million it held as security for costs in an international arbitration.
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.